Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker

Aging

Volumn 3, Issue 2, 2011, Pages 168-174

  Redon, Christophe E ^a   Nakamura, Asako J ^a   Martin, Olga A ^a   Parekh, Palak R ^a   Weyemi, Urbain S ^a   Bonner, William M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biomarker; Cancer; DNA damage; DNA repair; Double strand break; Senescent cells; H2AX

Indexed keywords

BIOLOGICAL MARKER; H2AFX PROTEIN, HUMAN; HISTONE;

ANIMAL; ARTICLE; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENETICS; HUMAN; METABOLISM; NEOPLASM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; HISTONES; HUMANS; NEOPLASMS; OBESITY;

EID: 79959536922     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100284     Document Type: Article

References (42)

1. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. gammaH2AX and cancer. Nat Rev Cancer. 2008; 8:957-967.
2. van Attikum H and Gasser SM. ATP-dependent chromatin remodeling and DNA double-strand break repair. Cell Cycle. 2005; 4:1011-1014.
3. Thiriet C and Hayes JJ. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol Cell. 2005; 18:617-622.
4. Rothkamm K and Horn S. gamma-H2AX as protein biomarker for radiation exposure. Ann Ist Super Sanita. 2009; 45:265-271.
5. Yuan J, Adamski R and Chen J. Focus on histone variant H2AX: to be or not to be. FEBS Lett. 2010; 584:3717-3724.
6. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science. 2002; 296:922-927.
7. Rothkamm K and Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003; 100:5057-5062.
8. Qvarnstrom OF, Simonsson M, Johansson KA, Nyman J, Turesson I. DNA double strand break quantification in skin biopsies. Radiother Oncol. 2004; 72:311-317.
9. Lobrich M, Rief N, Kuhne M, Heckmann M, Fleckenstein J,Rube C, Uder M. In vivo formation and repair of DNA doublestrand breaks after computed tomography examinations. Proc Natl Acad Sci U S A. 2005; 102:8984-8989.
10. Kuefner MA, Grudzenski S, Hamann J, Achenbach S, Lell M, Anders K, Schwab SA, Haberle L, Lobrich M, Uder M. Effect of CT scan protocols on x-ray-induced DNA doublestrand breaks in blood lymphocytes of patients undergoing coronary CT angiography. Eur Radiol. 2010; 20:2917-2924.
11. Kuefner MA, Grudzenski S, Schwab SA, Wiederseiner M, Heckmann M, Bautz W, Lobrich M, Uder M. DNA doublestrand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures. Invest Radiol. 2009; 44:440-446.
12. Sak A, Grehl S, Erichsen P, Engelhard M, Grannass A, Levegrun S, Pottgen C, Groneberg M, Stuschke M. gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment. Int J Radiat Biol. 2007; 83:639-652.
13. Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H. gamma-H2AX foci as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: are we underestimating radiation risks? Circulation. 2009; 120:1903-1909.
14. Rothkamm K, Balroop S, Shekhdar J, Fernie P, Goh V. Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. Radiology. 2007; 242:244-251.
15. Geisel D, Heverhagen JT, Kalinowski M, Wagner HJ. DNA double-strand breaks after percutaneous transluminal angioplasty. Radiology. 2008; 248:852-859.
16. Redon CE, Nakamura AJ, Gouliaeva K, Rahman A, Blakely WF, Bonner WM. The use of gamma-H2AX as a biodosimeter for total-body radiation exposure in non-human primates. PLoS One. 2010; 5:e15544.
17. Garty G, Chen Y, Salerno A, Turner H, Zhang J, Lyulko O, Bertucci A, Xu Y, Wang H, Simaan N, Randers-Pehrson G, Yao YL, Amundson SA, Brenner DJ. The RABIT: a rapid automated biodosimetry tool for radiological triage. Health Phys. 2010; 98:209-217.
18. Turner HC, Brenner DJ, Chen Y, Bertucci A, Zhang J, Wang H, Lyulko OV, Xu Y, Shuryak I, Schaefer J, Simaan N, Randers-Pehrson G, Yao YL, Amundson SA, Garty G. Adapting the gamma-H2AX Assay for Automated Processing in Human Lymphocytes. 1. Technological Aspects. Radiat Res. 2010; Dec 28, epub ahead of print
19. Sordet O, Redon CE, Guirouilh-Barbat J, Smith S, Solier S, Douarre C, Conti C, Nakamura AJ, Das BB, Nicolas E, Kohn KW, Bonner WM, Pommier Y. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep. 2009; 10:887-893.
20. Sedelnikova OA, Redon CE, Dickey JS, Nakamura AJ, Georgakilas AG, Bonner WM. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res. 2010.
21. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006; 6:789-802.
22. Kinders RJ, Hollingshead M, Lawrence S, Ji J, Tabb B, Bonner WM, Pommier Y, Rubinstein L, Evrard YA, Parchment RE, Tomaszewski J, Doroshow JH. Development of a validated immunofluorescence assay for gammaH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity. Clin Cancer Res. 2010; 16:5447-5457.
23. Wang LH, Pfister TD, Parchment RE, Kummar S, Rubinstein L, Evrard YA, Gutierrez ME, Murgo AJ, Tomaszewski JE, Doroshow JH, Kinders RJ. Monitoring druginduced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells. Clin Cancer Res. 2010; 16:1073-1084.
24. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009; 361:123-134.
25. Redon CE, Nakamura AJ, Zhang YW, Ji JJ, Bonner WM, Kinders RJ, Parchment RE, Doroshow JH, Pommier Y. Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res. 2010; 16:4532-4542.
26. Nagasawa H and Little JB. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res. 1992; 52:6394-6396.
27. Sokolov MV, Smilenov LB, Hall EJ, Panyutin IG, Bonner WM, Sedelnikova OA. Ionizing radiation induces DNA doublestrand breaks in bystander primary human fibroblasts. Oncogene. 2005; 24:7257-7265.
28. Prise KM and O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009; 9:351-360.
29. Nakamura AJ, Redon CE, Bonner WM, Sedelnikova OA. Telomere-dependent and telomere-independent origins of endogenous DNA damage in tumor cells. Aging. 2009; 1:212-218.
30. Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, Bonner WM. Intercellular Communication of Cellular Stress Monitored by {gamma}-H2AX Induction. Carcinogenesis. 2009; 30:1686-1695.
31. Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, Kryston TB, Bonner WM, Georgakilas AG, Sedelnikova OA. Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci U S A. 2010; 107:17992-17997.
32. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010; 17:332-341.
33. Bassaganya-Riera J, Misyak S, Guri AJ, Hontecillas R. PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammation. Cell Immunol. 2009; 258:138-146.
34. Villaret A, Galitzky J, Decaunes P, Esteve D, Marques MA, Sengenes C, Chiotasso P, Tchkonia T, Lafontan M, Kirkland JL , Bouloumie A. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes. 2010; 59:2755-2763.
35. Scarpato R, Verola C, Fabiani B, Bianchi V, Saggese G, Federico G. Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the {gamma}-H2AX focus assay and micronucleus test. FASEB J. 2011; 25:685-693.
36. Mondal NK, Mukherjee B, Das D, Ray MR. Micronucleus formation, DNA damage and repair in premenopausal women chronically exposed to high level of indoor air pollution from biomass fuel use in rural India. Mutat Res. 2010; 697:47-54.
37. Audebert M, Riu A, Jacques C, Hillenweck A, Jamin EL, Zalko D, Cravedi JP. Use of the gammaH2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. Toxicol Lett. 2010; 199: 182-192.
38. Yip KW, Cuddy M, Pinilla C, Giulanotti M, Heynen-Genel S, Matsuzawa SI, Reed JC. A High-Content Screening (HCS) Assay for the Identification of Chemical Inducers of PML Oncogenic Domains (PODs). J Biomol Screen. 2011; 16:251-258.
39. Matsuzaki K, Harada A, Takeiri A, Tanaka K, Mishima M. Whole cell-ELISA to measure the gammaH2AX response of six aneugens and eight DNA-damaging chemicals. Mutat Res. 2010; 700:71-79.
40. Soutoglou E and Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science. 2008; 320:1507-1510.
41. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle. 2009; 8:4112-4118.
42. Dmitrieva NI and Burg MB. Analysis of DNA breaks, DNA damage response, and apoptosis produced by high NaCl. Am J Physiol Renal Physiol. 2008; 295:F1678-1688.